Live Oak Private Wealth LLC Lowers Stock Position in HCA Healthcare, Inc. $HCA

Live Oak Private Wealth LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,268 shares of the company’s stock after selling 1,668 shares during the quarter. HCA Healthcare comprises approximately 1.7% of Live Oak Private Wealth LLC’s holdings, making the stock its 15th biggest position. Live Oak Private Wealth LLC’s holdings in HCA Healthcare were worth $12,971,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Brighton Jones LLC bought a new position in HCA Healthcare in the 4th quarter worth $1,021,000. NewEdge Advisors LLC lifted its position in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC grew its position in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Jump Financial LLC purchased a new position in HCA Healthcare in the 2nd quarter worth approximately $2,073,000. Finally, Sei Investments Co. grew its holdings in HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after buying an additional 49,214 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 0.3%

HCA stock opened at $413.02 on Wednesday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The stock has a market cap of $89.42 billion, a PE ratio of 13.83, a P/E/G ratio of 1.44 and a beta of 1.10. The company has a 50-day moving average price of $402.35 and a 200 day moving average price of $439.62.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the previous year, the business earned $6.84 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. Sell-side analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. dropped their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research report on Thursday, August 20th. UBS Group dropped their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a report on Monday, July 27th. Raymond James Financial set a $528.00 target price on HCA Healthcare in a research report on Tuesday, July 7th. Wells Fargo & Company raised their price target on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Finally, Mizuho lowered their target price on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.